Daniel Meyer is Head of Statistics for the Oncology Therapeutic
category for Pfizer Global Product Development. He held previous
group head roles at Pfizer for rare disease, infectious disease,
cardiovascular & metabolic disease, and nonclinical statistics.
Dan received his PhD in Statistics from the University of Wisconsin.
He is a Fellow of the American Statistical Association and has
previously served in a variety of chapter and section leadership
roles in ASA. Dan has been a member of the New England Rare Disease
Statistics Workshop organizing committee for the past few years.